SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in...
65 insider purchases on record · latest filing 2019-12-10.
Insiders have also filed 54 sale transactions at SIGA.